Prediction and classification of cardiovascular disease risk in older adults with diabetes

Diabetologia

Volumn 56, Issue 2, 2013, Pages 275-283

  Mukamal, K J ^a   Kizer, J R ^b   Djousse L ^c   Ix, J H ^d   Zieman, S ^e   Siscovick, D S ^f   Sibley, C T ^e   Tracy, R P ^g   Arnold, A M ^f  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF VERMONT   (United States)

Author keywords

Biological markers; Cardiovascular diagnostic techniques; Cardiovascular disease; Cohort; Diabetes; Regression analysis; Risk factors

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLASSIFICATION ALGORITHM; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSTRUMENT VALIDATION; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MULTI ETHNIC STUDY OF ATHEROSCLEROSIS; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CLASSIFICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, HDL; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RISK FACTORS; STROKE;

MLCS; MLOWN;

EID: 84878805626     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2772-1     Document Type: Article

References (43)

1. Sloan FA, Bethel MA, Ruiz D Jr, Shea AM, Feinglos MN (2008) The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med 168:192-199
2. Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ (2000) Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 20:823-829
3. Folsom AR, Chambless LE, Duncan BB, Gilbert AC, Pankow JS (2003) Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care 26:2777-2784
4. Howard BV, Best LG, Galloway JM et al (2006) Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 29:391-397
5. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847
6. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR (2008) C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 118:2243-2251
7. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ (2007) Screening for coronary artery disease in patients with diabetes. Diabetes Care 30:2729-2736
8. Nesto RW (1999) Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 22:1393-1395
9. Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301:1547-1555
10. Fried LP, Borhani NO, Enright P et al (1991) The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1:263-276
11. Bild DE, Bluemke DA, Burke GL et al (2002) Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156:871-881
12. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M (1992) Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 45:683-692
13. Smith NL, Heckbert SR, Bittner VA et al (1999) Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997. Diabetes Care 22:736-742
14. Smith NL, Psaty BM, Heckbert SR, Tracy RP, Cornell ES (1999) The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 52:143-146
15. Psaty BM, Kuller LH, Bild D et al (1995) Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5:270-277
16. Ives DG, Fitzpatrick AL, Bild DE et al (1995) Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5:278-285
17. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41:264-270
18. Patton KK, Ellinor PT, Heckbert SR et al (2009) N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation 120:1768-1774
19. Chonchol M, Katz R, Fried LF et al (2010) Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly. Nutr Metabol Cardiovasc Dis 20:15-21
20. Furberg CD, Manolio TA, Psaty BM et al (1992) Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol 69:1329-1335
21. Rautaharju PM, Calhoun HP, Chaitman BR (1992) NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. J Electrocardiol 24:179-187
22. O'Leary DH, Polak JF, Wolfson SK Jr et al (1991) Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 22:1155-1163
23. Newman AB, Siscovick DS, Manolio TA et al (1993) Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 88:837-845
24. Green DM, Ropper AH, Kronmal RA, Psaty BM, Burke GL (2002) Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology 59:314-320
25. Arnold AM, Kronmal RA (2003) Multiple imputation of baseline data in the cardiovascular health study. Am J Epidemiol 157:74-84
26. Lumley T, Kronmal RA, Cushman M, Manolio TA, Goldstein S (2002) A stroke prediction score in the elderly: validation and web-based application. J Clin Epidemiol 55:129-136
27. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387
28. Cleves M, Gutierrez R, Gould W, Marchenko Y (2010) An introduction to survival analysis using STATA. Stata Press, College Station
29. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157-172
30. Polonsky TS, McClelland RL, Jorgensen NW et al (2010) Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303:1610-1616
31. Detrano R, Guerci AD, Carr JJ et al (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358:1336-1345
32. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr (2011) Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 365:213-221
33. Coleman RL, Stevens RJ, Retnakaran R, Holman RR (2007) Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care 30:1292-1293
34. Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD (2005) Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed type 2 diabetes: results from a United Kingdom study. Diabet Med 22:554-562
35. Anand DV, Lim E, Hopkins D et al (2006) Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27:713-721
36. Adeniyi A, Folsom AR, Brancati FL, Desvorieux M, Pankow JS, Taylor H (2002) Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. J Natl Med Assoc 94:1025-1035
37. Elkeles RS, Godsland IF, Feher MD et al (2008) Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J 29:2244-2251
38. Stevens RJ, Kothari V, Adler AI, Stratton IM (2001) The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci 101:671-679
39. Conroy RM, Pyorala K, Fitzgerald AP et al (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987-1003
40. Ridker PM, Buring JE, Rifai N, Cook NR (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 297:611-619
41. de Boer IH, Katz R, Cao JJ et al (2009) Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care 32:1833-1838
42. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO (2004) Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 27:17-20
43. Pencina MJ, D'Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30:11-21